Quantitative Susceptibility Mapping of the Substantia Nigra in Parkinson’s Disease
Xinxin Zhao1, Hedi An2, Tian Liu3, Nan Shen2, Binshi Bo4, Zhuwei Zhang4, Pengfei Weng4, Meining Chen4, Mengchao Pei4, Yi Wang3,4, Dongya Huang2, and Jianqi Li4

1Shanghai Key Laboratory of Magnetic Resonance and Department of Physics, East China Normal University, Shanghai, China, People's Republic of, 2Dongfang Hospital Neural Medical Affiliated Tongji University, Shanghai, China, People's Republic of, 3Department of Radiology, Weill Medical College of Cornell University, New York, NY, United States, 4Department of physics, Shanghai Key Laboratory of Magnetic Resonance and Department of Physics, East China Normal University, Shanghai, China, People's Republic of

Synopsis

Quantitative susceptibility mapping (QSM) provides excellent contrast of iron-rich deep nuclei to quantify iron in the brains. Clinicians are interested in using QSM to diagnose PD patients. QSM and R2* values were measured in the whole substantia nigra in patients with PD and healthy controls. The significant difference between PD patients and healthy controls in the substantia nigra was found on QSM but not on R2* mapping.

Purpose

The purpose of this study was to quantify brain iron deposition in patients with Parkinson’s disease using quantitative susceptibility mapping (QSM) and R2* mapping, and to evaluate the sensitivity of both mapping methods in clinical diagnosis of Parkinson's disease.

Materials and Methods

Twenty-nine patients with idiopathic PD (67.9 ± 6.7 years old, 12 males and 17 females) and twenty-five healthy controls (HC) (64.7 ± 8.3 years old, 11 males and 14 females) were studied on a clinical 3T MRI system (Magnetom Trio Tim; Siemens Medical Solutions, Erlangen, Germany) with a 12 channel matrix coil. The QSM images and R2* maps were generated from processing the same three dimensional (3D) multi-echo gradient-echo sequence with the following parameters: TR = 60ms, TE1 = 6.8ms, ΔTE = 6.8ms, echoes number = 8, flip angle = 15˚, FOV = 240*180mm2, in-plane resolution = 0.625*0.625mm2, slice thickness = 2mm, number of slices = 96.

QSM images were reconstructed from the phase data using the Morphology Enabled Dipole Inversion (MEDI) algorithm 1. Regions of interest (ROIs) of the whole SN were drawn manually on the QSM images by two researchers.

Two-tailed Pearson correlation analysis was used to analyze the correlations of QSM and R2* values with the UPDRS-III score respectively, and the correlation between whole mean values of two maps in both groups respectively. Two-tailed t-test and an analysis of sensitivity and specificity were applied to the mean values of QSM and R2* of two groups.

Results

The substantia nigra in all R2* and QSM maps showed a high contrast to the surrounding tissue. Fig.1 shows representative QSM maps and R2* maps of two individuals, a 67 years old female healthy control subject and a 68 years old female PD patient. A significant Pearson’s coefficient was found between susceptibility and R2* values of the SN of both groups, with the regression of 0.71 (p<0.001, Fig.2) in HC group and 0.67 (p<0.001, Fig.3) in PD group, respectively. The susceptibility values for the SN was significantly higher in the patients with PD than in the HC (154.80±43.36ppb vs. 127.50±21.05ppb, P=0.006, Fig.4). However, no significant difference was found for the R2* value in the SN between two groups.

The receiver operating characteristic curves (ROC) showed that the QSM had higher sensitivity to classify PD patients than the R2* mapping, with the area under the curve was 0.68 and 0.51, respectively (Fig. 5). The UPDRS-III motor scores did not correlate with mean susceptibility or R2* values in PD group.

Discussion and conclusion

The mean values of QSM within the whole SN in patients with PD was significant higher than in healthy controls. Furthermore, our ROC result showed QSM, compared to R2*, had higher sensitivity to distinguish PD from controls. These results in the current study are in good agreement with previous studies 2-5. No significant correlation was found between QSM value and the UPDRS-III motor scores, which is consistent with one recent study 2 but inconsistent with another recent study 3. Further investigation with detailed characterization of patients including UPDRS-II, in addition to UPDRS-III, is needed to sort this out.

In summary, the significant difference between PD patients and healthy controls in the substantia nigra was found on QSM but not on R2* mapping. QSM provides a more accurate and sensitive MRI technology to detect the pathologic changes in the substantia nigra of patients with PD.

Acknowledgements

This study was supported in part by grants from The National Natural Science Foundation of China (81271533).

References

1.Liu T, Wisnieff C, Lou M, et al. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magnetic resonance in medicine. 2013; 69(2):467-476.

2.Guangwei Du M, PhD,Tian Liu, et al. Quantitative Susceptibility Mapping of the Midbrain in Parkinson's Disease. Movement Disorders. 2015; 00.

3.He N, Ling H, Ding B, et al. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping. Human brain mapping. 2015.

4.Murakami Y, Kakeda S, Watanabe K, et al. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR American journal of neuroradiology. 2015; 36(6):1102-1108.

5.Barbosa JH, Santos AC, Tumas V, et al. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. Magn Reson Imaging. 2015; 33(5):559-565.

Figures

Figure 1. Representative QSM maps (top row) and R2* maps (bottom row) of two individuals, a 67 years old female healthy control subject (a&c) and a 68 years old female PD patient (b&d). HC, healthy control; PD, patient with Parkinson’s Disease.

Figure 2.The correlation between magnetic susceptibility and R2* values in substantia nigra of healthy controls.

Figure 3.The correlation between magnetic susceptibility and R2* values in substantia nigra of patients with Parkinson’s Diseases.

Figure 4.Comparsion of mean susceptibility values (a) and R2* values (b) in the substantia nigra between healthy controls (HC) and patients with Parkinson’s Diseases (PD). *Significantly different between two groups (P <0.01).

Figure 5.The ROC curves for discriminating patients with PD and the healthy controls.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
1548